“…Thus, the driving force behind protein-poly(amino acid) complex formation is mainly electrostatic interaction. Note that the resolubilized-state protein displays its original function and structure, as is the case with various kinds of proteins, such as the therapeutic monoclonal antibodies of Panitumumab, Etanercept, Adalimumab, Infliximab, Omalizumab, and Rituximab; the peptide hormone of Carperitide; the enzyme drug of L-asparaginase; and the globins of thyroglobulin and immunoglobulin G [32][33][34]. The recovery of activity and secondary structure implies that the process of PPC precipitation does not affect the tertiary structure of protein.…”